UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 505

Sortiert nach

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

Leukemia, 2017-10, Vol.31 (10), p.2104-2113

2017

Link zum Volltext

Verfügbarkeit prüfen

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

Leukemia, 2017-07, Vol.31 (7), p.1570-1581

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

Leukemia, 2015-03, Vol.29 (3), p.696-704

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Leukemia, 2015-08, Vol.29 (8), p.1721-1729

2015

Link zum Volltext

Verfügbarkeit prüfen

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Haematologica (Roma), 2011-01, Vol.96 (1), p.87-95

2011

Link zum Volltext

Verfügbarkeit prüfen

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Haematologica (Roma), 2016-03, Vol.101 (3), p.e116

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

Leukemia, 2020-09, Vol.34 (9), p.2542-2542

2020

Link zum Volltext

Verfügbarkeit prüfen

Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ

BMJ open, 2022-02, Vol.12 (2), p.e055076-e055076

2022

Link zum Volltext

Verfügbarkeit prüfen

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Oncogene, 2009-11, Vol.28 (44), p.3866-3879

2009

Link zum Volltext

Verfügbarkeit prüfen

1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6)

European journal of cancer (1990), 2012-07, Vol.48, p.S265-S265

2012

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of H3K9 methyltransferase as a potent therapeutic target in multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e214-e215

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of RECQ1 helicase in multiple myeloma drug resistance

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e67-e67

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

Experimental hematology, 2005-11, Vol.33 (11), p.1402-1416

2005

Link zum Volltext

Verfügbarkeit prüfen

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

Haematologica (Roma), 2010-07, Vol.95 (7), p.1150-1157

2010

Link zum Volltext

Verfügbarkeit prüfen

752P Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer

Annals of oncology, 2022-09, Vol.33, p.S888

2022

Link zum Volltext

Verfügbarkeit prüfen

miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression

Oncotarget, 2015-11, Vol.6 (36), p.39165-39183

2015

Link zum Volltext

Verfügbarkeit prüfen

Biologie des multiplen Myeloms

Der Onkologe, 2014-03, Vol.20 (3), p.208-216

2014

Link zum Volltext

Verfügbarkeit prüfen

Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation

Cytotherapy (Oxford, England), 2006, Vol.8 (4), p.354-366

2006

Link zum Volltext

Verfügbarkeit prüfen

Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage

Cell cycle (Georgetown, Tex.), 2016-07, Vol.15 (14), p.1919-1928

2016

Link zum Volltext

Verfügbarkeit prüfen

The heterogeneity of human mesenchymal stem cell preparations—Evidence from simultaneous analysis of proteomes and transcriptomes

Experimental hematology, 2006-04, Vol.34 (4), p.536-548

2006

Link zum Volltext

Verfügbarkeit prüfen

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma

Oncotarget, 2015-03, Vol.6 (8), p.6431-6447

2015

Link zum Volltext

Verfügbarkeit prüfen

Interaction between myeloma cells and bone tissue

Radiologe, 2014-06, Vol.54 (6), p.545-550

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(414)
Mit Volltextzugriff
(417)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6)

Inhibition of H3K9 methyltransferase as a potent therapeutic target in multiple myeloma

Role of RECQ1 helicase in multiple myeloma drug resistance

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

752P Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer

miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression

Biologie des multiplen Myeloms

Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation

Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage

The heterogeneity of human mesenchymal stem cell preparations—Evidence from simultaneous analysis of proteomes and transcriptomes

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma

Interaction between myeloma cells and bone tissue

Suchergebnisse filtern